U.S. markets open in 3 hours 23 minutes
  • S&P Futures

    3,308.50
    -25.25 (-0.76%)
     
  • Dow Futures

    27,182.00
    -226.00 (-0.82%)
     
  • Nasdaq Futures

    11,237.00
    -100.75 (-0.89%)
     
  • Russell 2000 Futures

    1,492.90
    -14.10 (-0.94%)
     
  • Crude Oil

    38.97
    -0.32 (-0.81%)
     
  • Gold

    1,889.80
    -13.40 (-0.70%)
     
  • Silver

    23.83
    -0.61 (-2.50%)
     
  • EUR/USD

    1.1703
    -0.0043 (-0.36%)
     
  • 10-Yr Bond

    0.6450
    0.0000 (0.00%)
     
  • Vix

    26.74
    +0.55 (+2.10%)
     
  • GBP/USD

    1.2813
    -0.0047 (-0.36%)
     
  • USD/JPY

    105.6870
    +0.0320 (+0.03%)
     
  • BTC-USD

    10,714.04
    -130.17 (-1.20%)
     
  • CMC Crypto 200

    229.59
    -0.08 (-0.03%)
     
  • FTSE 100

    5,887.16
    -10.34 (-0.18%)
     
  • Nikkei 225

    23,185.12
    -353.98 (-1.50%)
     

Akero Therapeutics (AKRO) Jumps: Stock Rises 8.9%

Zacks Equity Research

Akero Therapeutics, Inc. AKRO was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $20.53–$26.76 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Akero Therapeutics. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Akero Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Akero Therapeutics, Inc. Price

Akero Therapeutics, Inc. Price
Akero Therapeutics, Inc. Price

Akero Therapeutics, Inc. price | Akero Therapeutics, Inc. Quote


A better-ranked stock in the Medical - Biomedical and Genetics industry is Emergent Biosolutions Inc. EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
 
Akero Therapeutics, Inc. (AKRO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.